Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Leases (2020 - 2025)

Neuroone Medical Technologies' Operating Leases history spans 6 years, with the latest figure at $110374.0 for Q4 2025.

  • For Q4 2025, Operating Leases fell 53.5% year-over-year to $110374.0; the TTM value through Dec 2025 reached $110374.0, down 53.5%, while the annual FY2025 figure was $143148.0, 26.36% down from the prior year.
  • Operating Leases reached $110374.0 in Q4 2025 per NMTC's latest filing, down from $143148.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $315673.0 in Q3 2021 to a low of $20982.0 in Q4 2023.
  • Average Operating Leases over 5 years is $186360.2, with a median of $194392.0 recorded in 2024.
  • Peak YoY movement for Operating Leases: tumbled 92.3% in 2023, then skyrocketed 1031.34% in 2024.
  • A 5-year view of Operating Leases shows it stood at $173314.0 in 2021, then soared by 57.17% to $272405.0 in 2022, then crashed by 92.3% to $20982.0 in 2023, then surged by 1031.34% to $237377.0 in 2024, then tumbled by 53.5% to $110374.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Operating Leases are $110374.0 (Q4 2025), $143148.0 (Q3 2025), and $175344.0 (Q2 2025).